Literature DB >> 33333294

Exosome-mediated improvement in membrane integrity and muscle function in dystrophic mice.

Ling Leng1, Xue Dong2, Xianjun Gao1, Ning Ran1, Mengyuan Geng1, Bingfeng Zuo1, Yingjie Wu1, Wei Li3, Hua Yan4, Gang Han5, HaiFang Yin6.   

Abstract

Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that leads to compromised cellular membranes, caused by the absence of membrane-bound dystrophin protein. Muscle membrane leakage results in disrupted intracellular homeostasis, protein degradation, and muscle wasting. Improving muscle membrane integrity may delay disease progression and extend the lifespan of DMD patients. Here, we demonstrate that exosomes, membranous extracellular vesicles, can elicit functional improvements in dystrophic mice by improving muscle membrane integrity. Systemic administration of exosomes from different sources induced phenotypic rescue and mitigated pathological progression in dystrophic mice without detectable toxicity. Improved membrane integrity conferred by exosomes inhibited intracellular calcium influx and calcium-dependent activation of calpain proteases, preventing the degradation of the destabilized dystrophin-associated protein complex. We show that exosomes, particularly myotube-derived exosomes, induced functional improvements and alleviated muscle deterioration by stabilizing damaged muscle membrane in dystrophic mice. Our findings suggest that exosomes may have therapeutic implications for DMD and other diseases with compromised membranes.
Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; calcium; dystrophin-associated protein complex; exosome; membrane integrity

Mesh:

Substances:

Year:  2020        PMID: 33333294      PMCID: PMC8058444          DOI: 10.1016/j.ymthe.2020.12.018

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  55 in total

1.  Four genes for the calpain family locate on four distinct human chromosomes.

Authors:  S Ohno; S Minoshima; J Kudoh; R Fukuyama; Y Shimizu; S Ohmi-Imajoh; N Shimizu; K Suzuki
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers.

Authors:  John G Quinlan; Brenda L Wong; Richard T Niemeier; Alexandra S McCullough; Linda Levin; Martin Emanuele
Journal:  Neuromuscul Disord       Date:  2006-11-21       Impact factor: 4.296

3.  Delivery Efficacy Differences of Intravenous and Intraperitoneal Injection of Exosomes: Perspectives from Tracking Dye Labeled and MiRNA Encapsulated Exosomes.

Authors:  Xueying Zhou; Zhelong Li; Wenqi Sun; Guodong Yang; Changyang Xing; Lijun Yuan
Journal:  Curr Drug Deliv       Date:  2020       Impact factor: 2.565

Review 4.  Therapeutic developments for Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Annemieke Aartsma-Rus
Journal:  Nat Rev Neurol       Date:  2019-07       Impact factor: 42.937

5.  Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.

Authors:  Kleopas A Kleopa; Anthi Drousiotou; Eleni Mavrikiou; Annita Ormiston; Theodoros Kyriakides
Journal:  Hum Mol Genet       Date:  2006-04-04       Impact factor: 6.150

6.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

Authors:  J E Brenman; D S Chao; H Xia; K Aldape; D S Bredt
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

Review 7.  Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control.

Authors:  A L McCall; L S Farhy
Journal:  Minerva Endocrinol       Date:  2013-06       Impact factor: 2.184

Review 8.  Immune-mediated pathology in Duchenne muscular dystrophy.

Authors:  Amy S Rosenberg; Montserrat Puig; Kanneboyina Nagaraju; Eric P Hoffman; S Armando Villalta; V Ashutosh Rao; Lalage M Wakefield; Janet Woodcock
Journal:  Sci Transl Med       Date:  2015-08-05       Impact factor: 17.956

9.  Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.

Authors:  Sushrut Kamerkar; Valerie S LeBleu; Hikaru Sugimoto; Sujuan Yang; Carolina F Ruivo; Sonia A Melo; J Jack Lee; Raghu Kalluri
Journal:  Nature       Date:  2017-06-07       Impact factor: 49.962

Review 10.  Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers.

Authors:  Evelyne M Houang; Yuk Y Sham; Frank S Bates; Joseph M Metzger
Journal:  Skelet Muscle       Date:  2018-10-10       Impact factor: 4.912

View more
  4 in total

1.  Serum extracellular vesicles for delivery of CRISPR-CAS9 ribonucleoproteins to modify the dystrophin gene.

Authors:  Nathalie Majeau; Annabelle Fortin-Archambault; Catherine Gérard; Joël Rousseau; Pouiré Yaméogo; Jacques P Tremblay
Journal:  Mol Ther       Date:  2022-05-26       Impact factor: 12.910

Review 2.  Therapeutic Application of Extracellular Vesicles-Capsulated Adeno-Associated Virus Vector via nSMase2/Smpd3, Satellite, and Immune Cells in Duchenne Muscular Dystrophy.

Authors:  Yasunari Matsuzaka; Yukihiko Hirai; Kazuo Hashido; Takashi Okada
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 3.  Tailored Extracellular Vesicles: Novel Tool for Tissue Regeneration.

Authors:  Linli Li; Peipei Wu; Hui Qian; Wenrong Xu; Hui Shi; Jiajia Jiang
Journal:  Stem Cells Int       Date:  2022-07-29       Impact factor: 5.131

Review 4.  Mesenchymal Stromal Cells and Their Secretome: New Therapeutic Perspectives for Skeletal Muscle Regeneration.

Authors:  Martina Sandonà; Lorena Di Pietro; Federica Esposito; Alessia Ventura; Antonietta Rosa Silini; Ornella Parolini; Valentina Saccone
Journal:  Front Bioeng Biotechnol       Date:  2021-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.